Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-233,750
Closed -$7.46M 35
2022
Q2
$7.46M Buy
+233,750
New +$7.86M 3.84% 19
2021
Q2
Sell
-304,940
Closed -$10.1M 38
2021
Q1
$10.1M Sell
304,940
-126,840
-29% -$3.82M 4.48% 9
2020
Q4
$12.1M Buy
431,780
+35,380
+9% +$825K 4.83% 7
2020
Q3
$7.68M Buy
396,400
+3,660
+0.9% +$72.3K 4.05% 11
2020
Q2
$7.64M Buy
392,740
+110,620
+39% +$1.89M 4.61% 6
2020
Q1
$4.05M Sell
282,120
-136,190
-33% -$2.19M 3.88% 14
2019
Q4
$7.45M Sell
418,310
-6,790
-2% -$114K 4.39% 8
2019
Q3
$6.78M Buy
+425,100
New +$5.94M 4.46% 9

Other funds holding KLAC

Marvin & Palmer Associates's KLAC Position: Q3 2022 in Review

Marvin & Palmer Associates sold out of KLA (KLAC) in Q3 2022, closing a stake of 233,750 shares — an estimated $7.46M sold.

Marvin & Palmer Associates first reported a position in KLAC in Q3 2019 and held it in 8 quarters. The position peaked at $12.1M in Q4 2020. 1,058 funds tracked by Wall St. Rank hold KLAC as of Q3 2022.

  • Marvin & Palmer Associates reported no remaining KLA position as of Q3 2022 after selling out during the quarter.
  • Marvin & Palmer Associates sold 233,750 KLA shares in Q3 2022, an estimated $7.46M.
  • Marvin & Palmer Associates first reported a position in KLA in Q3 2019 and held it in 8 quarters.
  • Marvin & Palmer Associates's KLA position peaked at $12.1M in Q4 2020.
  • 1,058 funds tracked by Wall St. Rank held KLA as of Q3 2022.

Based on Marvin & Palmer Associates's 13F filing for Q3 2022, filed 14 Nov 2022.